Global Sleep Apnea Device Market Research Report—Forecast till 2027

$4,450$6,250

Global Sleep Apnea Device Market is anticipated to exhibit a CAGR of 6.52% during the assessment period of 2020 to 2027, to surpass USD 7,683.72 Million by 2027.

Clear

Description

Global Sleep Apnea Device Market Research Report—Forecast till 2027

Market Overview
Global Sleep Apnea Device Market is anticipated to exhibit a CAGR of 6.52% during the assessment period of 2020 to 2027, to surpass USD 7,683.72 Million by 2027. The global market growth is driven by technological advancements in sleep apnea devices. There are many lucrative opportunities for the major market players to develop advanced, safe, and comfortable products in the future.
The global Sleep Apnea devices market is expected to record significant market growth during the review period. The increasing incidences of sleep apnea and the growing geriatric population which leads to respiratory disorders are the major factors creating a huge demand for sleep apnea devices during the global market. According to the report published by ResMed at the American Thoracic Society (ATS) 2018 International Conference, OSA afflicted more than 936 million people worldwide in 2018, which is almost 836% more than the affected population in 2007. Therefore, the increasing number of people suffering from this disorder has resulted in a rising demand for sleep apnea diagnostic devices.

Market Segmentation
Global Sleep Apnea Device Market has been classified into Type and End User.
Based on the type segment, the global sleep apnea device market has been bifurcated into diagnostic and therapeutic devices. Diagnostic devices are further divided into polysomnography devices, home sleep testing devices, pulse oximeters, sleep screening devices. Polysomnography devices dominated the market in 2019.
Polysomnography devices are applicable to observe sleep stages and cycles to identify when sleep patterns are disrupted and why. The rising number of product advancements and launches is also fuelling the growth of this segment.
Regional Analysis
Geographically, the Global Sleep Apnea Device Market has been classified into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is likely to drive the market during the review period owing to the largest market share in 2019. The regional market has been classified into North America and Latin America, with the North American market further bifurcated into the US and Canada. The regional market is driven by the increasing prevalence of Obstructive Sleep Apnea (OSA), rising patient adherence for positive airway pressure devices, and medical coverage for sleep apnea devices.
The European sleep apnea device market has been segmented into Western Europe and Eastern Europe. The increasing elderly population base prone to suffer from sleep disorders is expected to fuel the regional business growth.
Asia-Pacific has been classified into China, India, Japan, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is expected to witness the fastest market growth potential over the review period owing to the rising per capita health spending, the emerging healthcare sector in China, India, and Australia, rising need for sleep apnea device such as continuous positive airway pressure (CPAP) machine used for the diagnosis of sleep disorders, and the increasing patient population suffering from sleep apnea.
Major Players
The Key Players in the Global Sleep Apnea Device Market are Koninklijke Philips (Netherlands), ResMed (US), LivaNova (UK), Compumedics (Australia), Nihon Kohden (Japan), GE Healthcare (US), Natus Medica (US), BMC Medical (China), Cadwell (US), and Curative Medical (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENT
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 18

2.2 RESEARCH OBJECTIVE 18

2.3 MARKET STRUCTURE 18

2.4 ASSUMPTIONS & LIMITATIONS 19

3 RESEARCH METHODOLOGY
3.1 DATA MINING 20

3.2 SECONDARY RESEARCH 21

3.3 PRIMARY RESEARCH 21

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 22

3.5 FORECASTING TECHNIQUES 23

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 24

3.6.1 BOTTOM-UP APPROACH 25

3.6.2 TOP-DOWN APPROACH 25

3.7 DATA TRIANGULATION 25

3.8 VALIDATION 26

4 MARKET DYNAMICS
4.1 OVERVIEW 27

4.2 DRIVERS 28

4.2.1 TECHNOLOGICAL ADVANCEMENTS IN SLEEP APNEA DEVICES 28

4.2.2 GROWING USAGE OF ORAL APPLIANCES 28

4.2.3 RISING PREVALENCE OF SLEEP APNEA 28

4.2.4 BOOMING GERIATRIC POPULATION 28

4.2.5 INCREASING OBESITY 29

4.3 RESTRAINTS 29

4.3.1 UNDIAGNOSED POPULATION 29

4.3.2 HIGH COST OF DEVICES 30

4.4 OPPORTUNITIES 30

4.4.1 GROWING INVESTMENT IN R&D ACTIVITIES TO LAUNCH NOVEL PRODUCTS 30

4.5 COVID-19 IMPACT ANALYSIS 31

4.5.1 IMPACT ON SUPPLY CHAIN 31

4.5.2 IMPACT ON PRICING 31

4.5.3 IMPACT ON KEY PLAYERS 31

5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS 32

5.1.1 R&D AND DESIGNING 33

5.1.2 MANUFACTURING 33

5.1.3 DISTRIBUTION & SALES 33

5.1.4 POST-SALES MONITORING 33

5.2 PORTER’S FIVE FORCES MODEL 34

5.2.1 BARGAINING POWER OF SUPPLIERS 35

5.2.2 BARGAINING POWER OF BUYERS 35

5.2.3 THREAT OF NEW ENTRANTS 35

5.2.4 THREAT OF SUBSTITUTES 35

5.2.5 RIVALRY 35

6 GLOBAL SLEEP APNEA DEVICES MARKET, BY TYPE
6.1 OVERVIEW 36

6.2 DIAGNOSTIC DEVICES 37

6.2.1 POLYSOMNOGRAPHY DEVICES 38

6.2.2 HOME SLEEP TESTING DEVICES 38

6.2.3 PULSE OXIMETERS 39

6.2.4 SLEEP SCREENING DEVICES 39

6.3 THERAPEUTIC DEVICES 40

6.3.1 POSITIVE AIRWAY PRESSURE DEVICES 41

6.3.1.1 AUTOMATIC POSITIVE AIRWAY PRESSURE DEVICES 42

6.3.1.2 CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES 42

6.3.1.3 BILEVEL POSITIVE AIRWAY PRESSURE DEVICES 42

6.3.2 FACIAL INTERFACES 43

6.3.2.1 FULL-FACE MASKS 44

6.3.2.2 NASAL PILLOW MASKS 44

6.3.2.3 NASAL MASKS 44

6.3.3 ACCESSORIES 45

6.3.3.1 HUMIDIFIER ACCESSORIES 46

6.3.3.2 POWER ACCESSORIES 46

6.3.3.3 TRANSPORTATION ACCESSORIES 46

6.3.3.4 COMMUNICATION ACCESSORIES 47

6.3.3.5 CHIN RESTRAINTS 47

6.3.4 ORAL APPLIANCES 48

6.3.4.1 MANDIBULAR ADVANCEMENT DEVICES 49

6.3.4.2 TONGUE-RETAINING DEVICES 49

6.3.5 ADAPTIVE SERVO-VENTILATORS 49

6.3.6 SURGICAL DEVICES 50

7 GLOBAL SLEEP APNEA DEVICES MARKET, BY END USER
7.1 OVERVIEW 51

7.2 HOME CARE SETTINGS 51

7.3 SLEEP LABORATORIES & HOSPITALS 52

7.4 OTHERS 52

8 GLOBAL SLEEP APNEA DEVICES MARKET, BY REGION
8.1 OVERVIEW 53

8.2 AMERICAS 55

8.2.1 NORTH AMERICA 58

8.2.1.1 US 62

8.2.1.2 CANADA 64

8.2.2 LATIN AMERICA 67

8.3 EUROPE 70

8.3.1 WESTERN EUROPE 73

8.3.1.1 GERMANY 77

8.3.1.2 FRANCE 79

8.3.1.3 UK 82

8.3.1.4 ITALY 85

8.3.1.5 SPAIN 87

8.3.1.6 REST OF WESTERN EUROPE 90

8.3.2 EASTERN EUROPE 93

8.4 ASIA-PACIFIC 96

8.4.1 CHINA 99

8.4.2 JAPAN 102

8.4.3 INDIA 105

8.4.4 AUSTRALIA 107

8.4.5 SOUTH KOREA 110

8.4.6 REST OF ASIA-PACIFIC 113

8.5 MIDDLE EAST & AFRICA 116

8.5.1 MIDDLE EAST 119

8.5.2 AFRICA 122

9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW 125

9.2 COMPETITIVE BENCHMARKING 126

9.3 MAJOR GROWTH STRATEGY IN THE SLEEP APNEA DEVICE MARKET 127

9.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 128

9.5 KEY DEVELOPMENTS & GROWTH STRATEGIES 128

9.5.1 ACQUISITIONS 129

9.6 FINANCIAL MATRIX 130

10 COMPANY PROFILES
10.1 KONINKLIJKE PHILIPS NV (PHILIPS) 131

10.1.1 COMPANY OVERVIEW 131

10.1.2 FINANCIAL OVERVIEW 132

10.1.3 PRODUCTS/SERVICES OFFERED 132

10.1.4 KEY DEVELOPMENTS 133

10.1.5 SWOT ANALYSIS 133

10.1.6 KEY STRATEGIES 134

10.2 RESMED 135

10.2.1 COMPANY OVERVIEW 135

10.2.2 FINANCIAL OVERVIEW 135

10.2.3 PRODUCTS/SERVICES OFFERED 136

10.2.4 KEY DEVELOPMENTS 136

10.2.5 SWOT ANALYSIS 137

10.2.6 KEY STRATEGIES 137

10.3 LIVA NOVA (CYBERONICS) 138

10.3.1 COMPANY OVERVIEW 138

10.3.2 FINANCIAL OVERVIEW 138

10.3.3 PRODUCTS/SERVICES OFFERED 139

10.3.4 KEY DEVELOPMENTS 139

10.3.5 SWOT ANALYSIS 140

10.3.6 KEY STRATEGIES 140

10.4 COMPUMEDICS 141

10.4.1 COMPANY OVERVIEW 141

10.4.2 FINANCIAL OVERVIEW 141

10.4.3 PRODUCTS/SERVICES OFFERED 142

10.4.4 KEY DEVELOPMENTS 142

10.4.5 SWOT ANALYSIS 142

10.4.6 KEY STRATEGIES 143

10.5 NIHON KOHDEN 144

10.5.1 COMPANY OVERVIEW 144

10.5.2 FINANCIAL OVERVIEW 144

10.5.3 PRODUCTS/SERVICES OFFERED 145

10.5.4 KEY DEVELOPMENTS 145

10.5.5 SWOT ANALYSIS 146

10.5.6 KEY STRATEGIES 146

10.6 GE HEALTHCARE 147

10.6.1 COMPANY OVERVIEW 147

10.6.2 FINANCIAL OVERVIEW 147

10.6.3 PRODUCTS/SERVICES OFFERED 148

10.6.4 KEY DEVELOPMENTS 148

10.6.5 SWOT ANALYSIS 148

10.6.6 KEY STRATEGIES 148

10.7 NATUS MEDICAL INCORPORATED 149

10.7.1 COMPANY OVERVIEW 149

10.7.2 FINANCIAL OVERVIEW 149

10.7.3 PRODUCTS/SERVICES OFFERED 150

10.7.4 KEY DEVELOPMENTS 150

10.7.5 SWOT ANALYSIS 151

10.7.6 KEY STRATEGIES 151

10.8 BMC MEDICAL CO.LTD. 152

10.8.1 COMPANY OVERVIEW 152

10.8.2 FINANCIAL OVERVIEW 152

10.8.3 PRODUCTS/SERVICES OFFERED 152

10.8.4 KEY DEVELOPMENTS 152

10.8.5 SWOT ANALYSIS 153

10.8.6 KEY STRATEGIES 153

10.9 CADWELL LABORATORIES 154

10.9.1 COMPANY OVERVIEW 154

10.9.2 FINANCIAL OVERVIEW 154

10.9.3 PRODUCTS/SERVICES OFFERED 154

10.9.4 KEY DEVELOPMENTS 154

10.9.5 SWOT ANALYSIS 155

10.9.6 KEY STRATEGIES 155

10.10 CURATIVE MEDICAL INC. 156

10.10.1 COMPANY OVERVIEW 156

10.10.2 FINANCIAL OVERVIEW 156

10.10.3 PRODUCTS/SERVICES OFFERED 156

10.10.4 KEY DEVELOPMENTS 156

10.10.5 SWOT ANALYSIS 157

10.10.6 KEY STRATEGIES 157

11 APPENDIX
11.1 REFERENCES 158

11.2 RELATED REPORTS 158